Kivel Richard 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Oct 21, 2011
Insider Transaction Report
Form 4
Kivel Richard
Director
Transactions
- Purchase
Common Stock
2011-10-03$1.04/sh+2,500$2,600→ 2,500 total
Holdings
- 20,000
Stock Options (right-to-buy)
Exercise: $1.25Exp: 2021-06-06→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $1.19From: 2011-09-17Exp: 2010-09-17→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]These options vest and become exercisable in full on June 6, 2012.